Methyl N-(2-chlorophenyl)glycinate hydrochloride (1:1)

We are Methyl N-(2-chlorophenyl)glycinate hydrochloride (1:1) CAS:141109-15-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:    Methyl N-(2-chlorophenyl)glycinate hydrochloride (1:1)
CAS.NO:  141109-15-1
Synonyms:
(+)-2-chlorophenyl glycine methyl ester tartrate salt
(+-)-2-carboxy-1,1-dimethyl-piperidinium,chloride
Piperidinium,2-carboxy-1,1-dimethyl-,chloride

Molecular Formula: C9H11Cl2NO2
Molecular Weight: 236.09500

Physical and Chemical Properties:

Specification:
Appearance: White powder
Purity:≥99%
Loss on drying:≤0.50%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Refrigerator (+4°C).Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Clopidogrel sulfate CAS:120202-66-6
Intermediates of Clopidogrel CAS:113665-84-2
Intermediates of Clopidogrel camphorsulfonate CAS:120202-68-8

Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.5-metil furfural CAS:620-02-0 An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.1-Amino-2-(isopropylsulphonyl)benzene CAS:76697-50-2 An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.